BridgeMD
Continuous antibiotic infusion in children
EU CTIS ID: 2025-522809-38-00
What this study is testing
To evaluate the efficacy, safety and cost-efficiency of continuous (24 h) antibiotic infusion in children
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Iv-antibiotic treatment is necessary
- Clinically stable
- No need to stay in hospital
- Pump or cassette can be changed at the hospital or at home
- Care givers are able to contact hospital if needed
- Clinical diagnose is not uncertain
You likely can't join if
- The pump cannot be carried with the child
- The child must stay at the hospital for monitoring or other reason
- Unclear diagnose
See the full eligibility criteria
- Iv-antibiotic treatment is necessary
- Clinically stable
- No need to stay in hospital
- Pump or cassette can be changed at the hospital or at home
- Care givers are able to contact hospital if needed
- Clinical diagnose is not uncertain
- No allergy for the used antibiotic
- The continuous antibiotic infusion hasn’t been started yet or it has been initiated no more than 24 hours prior to study enrolment
- The pump cannot be carried with the child
- The child must stay at the hospital for monitoring or other reason
- Unclear diagnose
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.